Form4insider filings, from the source

Insider holders · CIK 0000715446

Anixa Biosciences Inc · ANIX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Lewis H Titterton Jr.Director1,046,003—1,046,003Sep 25, 2026 · 8:39 am EDTForm 4
Amit KumarChief Executive Officer665,000—665,000Sep 14, 2026 · 9:45 am EDTForm 4
Bruce F JohnsonDirector604,817—604,817Sep 26, 2017 · 7:49 pm EDTForm 4
Arnold M BaskiesDirector135,572—135,572Jul 29, 2026 · 9:14 am EDTForm 4
Richard H WilliamsDirector25,00050,00075,000Apr 11, 2018 · 5:39 pm EDTForm 4/A
Robert Andrew BermanPresident & CEO61,553—61,553Jun 5, 2017 · 10:52 am EDTForm 4
John J MonahanDirector50,000—50,000Sep 26, 2017 · 8:26 pm EDTForm 4
Henry P HermsVP, Finance & CFO23,321—23,321Oct 24, 2016 · 4:36 pm EDTForm 4
Michael CatelaniCOO & CFO2,250—2,250Sep 19, 2018 · 11:47 am EDTForm 4
David CavalierDirector0—0Oct 1, 2018 · 5:33 pm EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.